
Candaur Pharmaceuticals Private Limited
Pharmaceutical trading and marketing for government and international markets.
Pharmaceutical trading and marketing for government and international markets.
Candaur Pharmaceuticals Private Limited (CPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 June 2005 and has a history of 19 years and ten months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.20 M.
The company currently has active open charges totaling ₹1.64 Cr.
Manas Patnaik, Pragyan Patnaik, Supriya Mohanty, and One other member serve as directors at the Company.
Thane, Maharashtra, India
+91-XXXXXXXXXX
U24230MH2005PTC154284
154284
Private Limited Indian Non-Government Company
28 Jun 2005
30 Sep 2024
31 Mar 2024
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Manas Patnaik ![]() | Director | 01-Jul-2005 | Current |
Pragyan Patnaik ![]() | Director | 01-Jul-2005 | Current |
Supriya Mohanty ![]() | Director | 01-Jul-2015 | Current |
Geetika Gupta ![]() | Additional Director | 16-Mar-2018 | Current |
Candaur Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 61.2% increase. The company also saw a substantial improvement in profitability, with a 45.24% increase in profit. The company's net worth Soared by an impressive increase of 11.26%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Candaur Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Supriya Mohanty is a mutual person
Geetika Gupta is a mutual person
Geetika Gupta is a mutual person
Geetika Gupta is a mutual person
₹16.42 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
15 Mar 2014 | Others | ₹1.64 Cr | Open |
Unlock and access historical data on people associated with Candaur Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Candaur Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Candaur Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Candaur Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Candaur Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
A charge with Others of Rs. 16.42 M registered on 15 Mar 2014 with Charge ID 10500640 was modified on 18 May 2023.
Geetika Gupta was appointed as a Additional Director was appointed as a Additional Director on 16 Mar 2018 & has been associated with this company since 7 years 1 month .
Supriya Mohanty was appointed as a Director was appointed as a Director on 01 Jul 2015 & has been associated with this company since 9 years 10 months .
A charge with Others amounted to Rs. 16.42 M with Charge ID 10500640 was registered on 15 Mar 2014.
Candaur Pharmaceuticals Private Limited was incorporated on 28 Jun 2005.
The authorized share capital of Candaur Pharmaceuticals Private Limited is ₹ 2.50 M and paid-up capital is ₹ 2.20 M.
Currently 4 directors are associated with Candaur Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Candaur Pharmaceuticals Private Limited is Shop No 17 Iris Building Jangir Enclave Beverly Park, (E) India, Mira Road, Maharashtra, 401107.
The corporate identification number (CIN) of Candaur Pharmaceuticals Private Limited is U24230MH2005PTC154284 and the company number is 154284 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Candaur Pharmaceuticals Private Limited has risen by 61.20%.
The financial reports for the fiscal year 2023 indicates that The net worth of Candaur Pharmaceuticals Private Limited has experienced an upsurge of 11.26%.
As per the financial statements for fiscal Year 2023, The total open charges for Candaur Pharmaceuticals Private Limited amount to ₹ 1.64 Cr.
The most recent Balance Sheet for Candaur Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
IR
NS